β-adrenergic blockade in chronic heart failure: Principles, progress, and practice
- 31 August 1998
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 41 (1) , 39-52
- https://doi.org/10.1016/s0033-0620(98)80030-3
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the diseaseThe American Journal of Cardiology, 1993
- Usefulness of bucindolol in congestive heart failureThe American Journal of Cardiology, 1990
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.Circulation, 1985
- Coronary vasoconstriction and catecholamine cardiomyopathyAmerican Heart Journal, 1985
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.Circulation, 1979
- Plasma norepinephrine in congestive heart failurePublished by Elsevier ,1978